187 related articles for article (PubMed ID: 22123293)
1. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
Izrailit J; Reedijk M
Cancer Lett; 2012 Apr; 317(2):115-26. PubMed ID: 22123293
[TBL] [Abstract][Full Text] [Related]
2. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
Ma Y; Wang HX
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
[No Abstract] [Full Text] [Related]
3. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stem cells: a novel therapeutic target.
Gangopadhyay S; Nandy A; Hor P; Mukhopadhyay A
Clin Breast Cancer; 2013 Feb; 13(1):7-15. PubMed ID: 23127340
[TBL] [Abstract][Full Text] [Related]
5. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
O'Toole SA; Swarbrick A; Sutherland RL
Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
7. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
9. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
Kiesslich T; Neureiter D
Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
11. Involvement of microRNAs in breast cancer.
Adams BD; Guttilla IK; White BA
Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
[TBL] [Abstract][Full Text] [Related]
12. Implications of stemness-related signaling pathways in breast cancer response to therapy.
Angeloni V; Tiberio P; Appierto V; Daidone MG
Semin Cancer Biol; 2015 Apr; 31():43-51. PubMed ID: 25153354
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
[TBL] [Abstract][Full Text] [Related]
14. Developmental signaling pathways in brain tumor-derived stem-like cells.
Clark PA; Treisman DM; Ebben J; Kuo JS
Dev Dyn; 2007 Dec; 236(12):3297-308. PubMed ID: 18000980
[TBL] [Abstract][Full Text] [Related]
15. Emerging targets for hematological malignancies.
Cilloni D; Frassoni F; Saglio G
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
[TBL] [Abstract][Full Text] [Related]
16. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies.
Vera-Ramirez L; Sanchez-Rovira P; Ramirez-Tortosa MC; Ramirez-Tortosa CL; Granados-Principal S; Lorente JA; Quiles JL
Crit Rev Oncol Hematol; 2011 Dec; 80(3):347-68. PubMed ID: 21288735
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell: target for anti-cancer therapy.
Tang C; Ang BT; Pervaiz S
FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071
[TBL] [Abstract][Full Text] [Related]
18. Biological therapy of breast cancer: recent clinical applications.
Baar J
Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
[TBL] [Abstract][Full Text] [Related]
19. Novel targeted agents for the treatment of advanced breast cancer.
de la Vega M; Díaz-Cantón E; Alvarez RH
Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
Stratford AL; Reipas K; Maxwell C; Dunn SE
Expert Rev Mol Med; 2010 Jul; 12():e22. PubMed ID: 20653987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
